Shrestha A, Navarro M, Beingesser J, Armien A, Uzal F, McClane B
mSphere. 2022; 7(5):e0027622.
PMID: 36069435
PMC: 9599344.
DOI: 10.1128/msphere.00276-22.
Shrestha A, Mehdizadeh Gohari I, McClane B
mBio. 2019; 10(6).
PMID: 31848291
PMC: 6918092.
DOI: 10.1128/mBio.02985-19.
Navarro M, Shrestha A, Freedman J, Beingesser J, McClane B, Uzal F
Infect Immun. 2019; 87(4).
PMID: 30642896
PMC: 6434118.
DOI: 10.1128/IAI.00670-18.
Shrestha A, Uzal F, McClane B
Microbiol Spectr. 2018; 6(5).
PMID: 30238869
PMC: 6736584.
DOI: 10.1128/microbiolspec.GPP3-0003-2017.
Freedman J, Hendricks M, McClane B
mSphere. 2017; 2(4).
PMID: 28875177
PMC: 5577654.
DOI: 10.1128/mSphere.00352-17.
The interaction of Clostridium perfringens enterotoxin with receptor claudins.
Shrestha A, Uzal F, McClane B
Anaerobe. 2016; 41:18-26.
PMID: 27090847
PMC: 5050067.
DOI: 10.1016/j.anaerobe.2016.04.011.
Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications.
Freedman J, Shrestha A, McClane B
Toxins (Basel). 2016; 8(3).
PMID: 26999202
PMC: 4810218.
DOI: 10.3390/toxins8030073.
Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.
Chen J, Theoret J, Shrestha A, Smedley 3rd J, McClane B
Infect Immun. 2012; 80(12):4078-88.
PMID: 22966051
PMC: 3497400.
DOI: 10.1128/IAI.00069-12.
Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins.
Kitadokoro K, Nishimura K, Kamitani S, Fukui-Miyazaki A, Toshima H, Abe H
J Biol Chem. 2011; 286(22):19549-55.
PMID: 21489981
PMC: 3103334.
DOI: 10.1074/jbc.M111.228478.
Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.
Kimura J, Abe H, Kamitani S, Toshima H, Fukui A, Miyake M
J Biol Chem. 2009; 285(1):401-8.
PMID: 19903817
PMC: 2804187.
DOI: 10.1074/jbc.M109.051417.
Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.
Smedley 3rd J, Saputo J, Parker J, Fernandez-Miyakawa M, Robertson S, McClane B
Infect Immun. 2008; 76(8):3793-800.
PMID: 18505809
PMC: 2493238.
DOI: 10.1128/IAI.00460-08.
Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.
Kokai-Kun J, Benton K, Wieckowski E, McClane B
Infect Immun. 1999; 67(11):5634-41.
PMID: 10531210
PMC: 96936.
DOI: 10.1128/IAI.67.11.5634-5641.1999.
Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y
J Cell Biol. 1999; 147(1):195-204.
PMID: 10508866
PMC: 2164970.
DOI: 10.1083/jcb.147.1.195.
Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin.
Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N
J Cell Biol. 1997; 136(6):1239-47.
PMID: 9087440
PMC: 2132509.
DOI: 10.1083/jcb.136.6.1239.
Deletion analysis of the Clostridium perfringens enterotoxin.
Kokai-Kun J, McClane B
Infect Immun. 1997; 65(3):1014-22.
PMID: 9038311
PMC: 175083.
DOI: 10.1128/IAI.65.3.1014-1022.1997.
Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.
Hanna P, Wnek A, McClane B
J Bacteriol. 1989; 171(12):6815-20.
PMID: 2556374
PMC: 210581.
DOI: 10.1128/jb.171.12.6815-6820.1989.
Epitope mapping of the alpha-toxin of Clostridium perfringens.
Logan A, Williamson E, Titball R, Percival D, Shuttleworth A, Conlan J
Infect Immun. 1991; 59(12):4338-42.
PMID: 1718874
PMC: 259046.
DOI: 10.1128/iai.59.12.4338-4342.1991.
A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
Mietzner T, Kokai-Kun J, Hanna P, McClane B
Infect Immun. 1992; 60(9):3947-51.
PMID: 1500207
PMC: 257418.
DOI: 10.1128/iai.60.9.3947-3951.1992.
Mapping of functional regions of Clostridium perfringens type A enterotoxin.
Hanna P, Wieckowski E, Mietzner T, McClane B
Infect Immun. 1992; 60(5):2110-4.
PMID: 1373406
PMC: 257123.
DOI: 10.1128/iai.60.5.2110-2114.1992.